NeuroNation

NeuroNation, operated by the German digital health company Synaptikon GmbH, provides a digital platform for cognitive training designed to improve memory, concentration, and processing speed. The company was co-founded by Rojahn Ahmadi, Jakob Futorjanski, and Ilya Shabanov. Ahmadi and Shabanov, who share a background in computer science, previously developed online games together. Futorjanski focused on artificial intelligence in finance before joining Rocket Internet and later teaming up with Ahmadi and Shabanov. The founders' journey began with a shared academic background in computer science and artificial intelligence, which they applied to create NeuroNation. The project started in late 2008 and became a full-time endeavor in the summer of 2010 after receiving a scholarship from BEUTH University.

The company targets individuals seeking to enhance cognitive functions, as well as patients recovering from strokes, brain injuries, or those with neurodegenerative conditions. Its primary product is a mobile and web application that offers personalized training plans, exercises, and games based on an initial assessment. The platform uses gamification to motivate its more than 25 million users. A specialized medical device version, NeuroNation MED, is a CE-approved Class 1 medical product for users with cognitive impairments and can be prescribed by doctors in Germany, with costs covered by some health insurers. The business model is primarily subscription-based, offering premium features through monthly, yearly, and lifetime plans under a freemium structure. Some content is free, while advanced features require a paid subscription.

NeuroNation collaborates with research institutions like the FU Berlin and Charité University Hospital to ensure its exercises are scientifically validated. The company's effectiveness is supported by studies showing improvements in memory, processing speed, and executive functions for its users. It has received accolades such as the AOK-Leonardo, a digital prevention award from the German Federal Ministry of Health, in 2013. The company has secured funding from investors including Impact Partners, Spiegel, and XLHealth AG.

Keywords: cognitive training, brain health, digital therapeutics, neurorehabilitation, memory improvement, mental fitness, gamified learning, cognitive assessment, neurodegenerative disease prevention, digital health, concentration training, cognitive enhancement, mobile health, brain exercises, personalized training, CE-marked medical device, Synaptikon, cognitive science, health technology, brain performance, attention training, executive function